What is the recommended treatment for croup in children aged 6 months to 3 years, including corticosteroid dosing and indications for adding nebulized epinephrine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Croup in Children

Administer oral dexamethasone 0.15-0.6 mg/kg (maximum 10-12 mg) as a single dose to ALL children with croup, regardless of severity, and reserve nebulized epinephrine 0.5 mL/kg of 1:1000 solution (maximum 5 mL) for moderate to severe cases with stridor at rest or significant respiratory distress. 1

First-Line Treatment: Corticosteroids for All Cases

  • Oral dexamethasone is the gold standard for croup treatment at any severity level 1
  • The recommended dose range is 0.15-0.6 mg/kg as a single dose, with a maximum of 10-12 mg 1
  • Research confirms that 0.15 mg/kg is equally effective as 0.6 mg/kg for moderate to severe croup, with no difference in croup score reduction at any time point 2
  • The lower dose (0.15 mg/kg) may be preferred to minimize steroid exposure while maintaining efficacy 2
  • Onset of action is approximately 6 hours after administration, so symptoms may not improve immediately 3

Alternative Corticosteroid Options

  • Nebulized budesonide 500-2000 µg reduces symptoms within the first 2 hours and has equivalent efficacy to oral dexamethasone 4
  • Intramuscular dexamethasone 0.6 mg/kg is appropriate for children who cannot tolerate oral medication 3, 5

When to Add Nebulized Epinephrine

Reserve nebulized epinephrine for moderate to severe croup only, defined by: 1, 5

  • Stridor at rest (not just with agitation or crying)
  • Significant respiratory distress with accessory muscle use
  • Respiratory rate >70 breaths/min in infants
  • Oxygen saturation <92%

Epinephrine Dosing

  • Standard dose: 0.5 mL/kg of 1:1000 solution (maximum 5 mL) via nebulizer 1
  • Recent evidence shows 0.1 mg/kg is non-inferior to 0.5 mg/kg for moderate to severe croup, though the higher dose remains standard 6
  • The traditional racemic epinephrine dose is 0.5 mL of 2.25% solution diluted in 2.5 mL saline 7
  • Effect lasts only 1-2 hours, requiring close monitoring for rebound symptoms 4, 3

Critical Observation Requirements After Epinephrine

  • Mandatory observation for at least 2 hours after the last epinephrine dose to monitor for rebound airway obstruction 1, 4, 3
  • Never discharge within 2 hours of epinephrine administration 1
  • Never use epinephrine in outpatient settings where immediate return is not feasible 1, 4

Hospitalization Criteria

Admit patients who meet any of the following: 1

  • Require ≥3 doses of nebulized epinephrine
  • Oxygen saturation <92%
  • Age <18 months
  • Respiratory rate >70 breaths/min
  • Persistent respiratory distress despite treatment
  • Persistent stridor at rest after treatment 4

Important Hospitalization Nuance

  • Do not admit after only 1-2 doses of epinephrine if a third dose could be safely administered in the emergency department, as this unnecessarily increases hospitalization rates 1
  • The threshold of 3 doses can reduce hospitalization rates by 37% without increasing revisits or readmissions 4

Treatment Algorithm by Severity

Mild Croup (No Stridor at Rest)

  • Oral dexamethasone 0.15-0.6 mg/kg alone 1
  • Observation for 2-3 hours to ensure symptoms are improving 4
  • No nebulized treatments needed 4

Moderate to Severe Croup (Stridor at Rest)

  • Oral dexamethasone 0.15-0.6 mg/kg PLUS nebulized epinephrine 0.5 mL/kg of 1:1000 solution 1
  • Administer epinephrine immediately while waiting for dexamethasone to take effect (6-hour onset) 3, 5
  • Simultaneous administration reduces intubation rates in severe croup with impending respiratory failure 5
  • Observation for minimum 2 hours after last epinephrine dose 1, 4

Discharge Criteria

Patients may be discharged when ALL of the following are met: 4

  • Resolution of stridor at rest
  • Minimal or no respiratory distress
  • Adequate oral intake
  • At least 2 hours have passed since last epinephrine dose
  • Parents can recognize worsening symptoms and understand return precautions

Common Pitfalls to Avoid

  • Never rely on cool mist therapy as definitive treatment—it lacks evidence of benefit 1
  • Never use antibiotics routinely—croup is viral in etiology 1, 7
  • Never discharge too early after nebulized epinephrine (before 2-hour observation) 4
  • Never fail to administer corticosteroids even in mild cases 4
  • Never withhold dexamethasone thinking the case is "too mild"—early intervention reduces return visits and hospital admissions 5
  • Never use lower steroid doses than 0.15 mg/kg, as they have proven ineffective 3

Supportive Care

  • Maintain at least 50% relative humidity in the child's room 3
  • Ensure adequate hydration 7
  • Provide fever control as needed 7
  • Avoid agitation—crying and distress worsen airway obstruction 3
  • Antihistamines and decongestants have no proven effect on viral croup 7

References

Guideline

Treatment of Classical Croup

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Croup.

The Journal of family practice, 1993

Guideline

Treatment of Croup with Nebulization

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Viral croup: a current perspective.

Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.